Peter K.
- Country
- Germany
- Department
- Neurology Dep. of Ambulant Health Center
Research Overview
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Intrathecal BIIB080 in Adults 50–80 y with MCI due to Alzheimer’s Disease or Mild AD Dementia
Data & Insights
Has run more than one trial at 56 of 67 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in the study of Alzheimer's Disease and its various manifestations, with particular emphasis on mild cognitive impairment and early-stage dementia conditions.
- Cognitive Function Assessment
- Early-Stage Dementia Research
- Age-Related Cognitive Decline
Their research focuses on evaluating cognitive changes in adults between 50 to 80 years of age.
Clinical Assessment Methods
The investigator employs specialized clinical assessment tools, particularly the Clinical Dementia Rating-Sum of Boxes (CDR-SB), to evaluate cognitive and functional performance in patients.
- Longitudinal Assessment Techniques
- Cognitive Performance Metrics
- Functional Status Evaluation
Their expertise includes tracking cognitive changes over extended observation periods.
Therapeutic Applications
The investigator explores innovative therapeutic approaches involving cerebrospinal fluid administration of experimental treatments for cognitive disorders.
- Novel Treatment Approaches
- Safety Assessment Protocols
- Therapeutic Response Monitoring
Their work encompasses both safety evaluation and therapeutic efficacy assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.